Placebo Turbuhaler®

DRUG3 trials

Sponsors

AstraZeneca

Conditions

AsthmaCOPDHealthy

Phase 1

Assess Safety, Tolerability and PK of AZD3199 in Japanese

CompletedNCT00772759

AstraZenecaHealthy

Start: 2008-10-31End: 2009-02-28Updated: 2009-05-05

A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease

TerminatedNCT01016951

AstraZenecaCOPD, Healthy

Start: 2009-12-31End: 2010-06-30Target: 36Updated: 2010-11-19

Phase 3

To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study

CompletedNCT01096017

AstraZenecaAsthma

Start: 2010-03-31End: 2010-04-30Updated: 2012-08-31

Related Papers

Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: analysis of two Phase I, randomised, double-blind, placebo-controlled studies.

2014-03-275 citations